February 12, 2018 by Scot Meyer and Chain Drug Review
beauty imagery, beauty marketing, CVS Beauty Mark, CVS Health, CVS Pharmacy, Helena Foulkes
2018, Issue 02-12-2018, Issues, News
WOONSOCKET, R.I. — Beginning in April, the beauty imagery that CVS Pharmacy produces for use in its stores and in its marketing materials will not be “materially altered” digitally. The drug chain is also asking its supplier partners to participate in the initiative, which is meant promote transparency in beauty marketing. “What we’re trying to
February 12, 2018 by Greg Jacobson and Chain Drug Review
Amazon, Amazon-Berkshire Hathaway-JPMorgan Chase health care company, Berkshire Hathaway, Beth Galetti, Jamie Dimon, Jeff Bezos, JPMorgan Chase, Marvell Sullivan Berchtold, Todd Combs, Warren Buffett
2018, Issue 02-12-2018, Issues, News
NEW YORK — Amazon, Berkshire Hathaway and JPMorgan Chase & Co. plan to form an independent, nonprofit health care company to provide their employees better and more affordable health care. While details remain sparse, the Amazon-Berkshire Hathaway-JPMorgan Chase health care company is considered a long-term effort that will focus initially on developing technology solutions to
February 12, 2018 by Geoff Walden and Chain Drug Review
Canadian generic drug prices, Canadian Generic Pharmaceutical Association, Canadian Pharmaceutical Alliance, Desjardins Capital Markets, Eric La Flèche, Keith Howlett, Loblaw, lower generic drug prices, Metro Inc., Richard Dufresne, Shoppers Drug Mart
2018, Issue 02-12-2018, Issues, Leading Headlines, News, Pharmacy, Retail News
TORONTO — Pharmacy operators across Canada will be hit hard by lower generic drug prices set to take effect this spring, said Metro Inc. chief executive officer Eric La Fleche. The pan-Canadian Pharmaceutical Alliance — which represents the provincial, territorial and federal governments — and the Canadian Generic Pharmaceutical Association announced late last month that
February 12, 2018 by Chain Drug Review
Richard Ashworth, Rick Gates, Walgreens, Walgreens Boots Alliance
2018, Issue 02-12-2018, Issues, News
DEERFIELD, Ill. — Rick Gates has been named senior vice president of pharmacy and health care for Walgreens. Gates most recently served as group vice president of pharmacy. With the promotion, he will oversee commercial development and sales, contracting, pharma development, pharmacy supply chain, and clinical programs and alliances, Walgreens Boots Alliance (WBA) said. He
February 12, 2018 by Brian Bossetta and Chain Drug Review
Adam Wampler, Bartell Drugs, George Bartell, Kathi Lentzsch
2018, Issue 02-12-2018, Issues, News
SEATTLE — Bartell Drugs, the country’s largest and oldest family-owned pharmacy, announced two significant hires to its executive ranks last month, including Kathi Lentzsch as the company’s chief executive officer, who becomes only the fifth CEO in the company’s 128-year history. Lentzsch comes to the company with more than three decades of retail experience with
February 12, 2018 by Bill Schiffner
John Standley, Rite Aid, Rite Aid category management staff, Walgreens Boots Alliance
2018, Issue 02-12-2018, Issues, News
CAMP HILL, Pa. — Rite Aid Corp. is making changes to its category management team as it proceeds with an asset sale in which more than 40% of its drug stores will be transferred to Walgreens Boots Alliance (WBA). The Rite Aid category management staff changes are under way, a company spokeswoman confirmed but declined
February 12, 2018 by Geoff Walden and Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, DIR fees, direct and indirect remuneration fees, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, NCPA, PCMA, Pharmaceutical Care Management Association, Steve Anderson
2018, Issue 02-12-2018, Issues, News
ARLINGTON, Va. — The “untenable” procedures around direct and indirect remuneration fees (DIR fees) can be righted with measures reducing costs for beneficiaries and the government, while promoting a more quality-driven health care system, says the National Association of Chain Drug Stores. NACDS expressed that message in comments to the Centers for Medicare & Medicaid
February 12, 2018 by Greg Jacobson and Chain Drug Review
Alex Azar, Eli Lilly, Food and Drug Administration, HHS secretary, prescription drug prices, President Donald Trump, Secretary of Health and Human Services, State of the Union, Trump's State of the Union address
2018, Issue 02-12-2018, Issues, Leading Headlines, News, Pharmacy, Retail News
WASHINGTON — In his first State of the Union speech, President Donald Trump renewed his pledge to reduce prescription drug prices, days after a former big pharma executive was sworn in as Secretary of Health and Human Services. Trump had stunned the pharmaceutical industry during his 2016 campaign by declaring that drug manufacturers were “getting
February 12, 2018 by Chain Drug Review
Genoa, Genoa Healthcare, John Figueroa
2018, Issue 02-12-2018, Issues, News
TUKWILA, Wash. — Genoa, a QoL Healthcare Company, announced an organizational rebranding as well as a name change to Genoa Healthcare. The comprehensive effort elevates the focus on the variety of services the organization provides for helping individuals living with behavioral health and other complex, chronic conditions. In addition to a new name, the Genoa
February 12, 2018 by Brian Bossetta
2018 NACDS Annual Meeting, Jim Collins, NACDS, National Association of Chain Drug Stores, Peggy Noonan, Steve Anderson
2018, Issue 02-12-2018, Issues, News
ARLINGTON, Va. — The National Association of Chain Drug Stores has slated two top speakers for its Sunday Business Program at the 2018 NACDS Annual Meeting, which will be held April 21 to April 24 in Palm Beach, Fla. — Pulitzer-prize winning columnist Peggy Noonan and author and management educator Jim Collins. Noonan’s writing for
February 12, 2018 by Scot Meyer and Chain Drug Review
Jill Turner-Mitchael, Sam's Club, Sean Jackson, Walmart
2018, Issue 02-12-2018, Issues, News
BENTONVILLE, Ark. — Sam’s Club has tapped Sean Jackson to succeed Jill Turner-Mitchael as senior vice president for consumables and health and wellness. Jackson, who joined Sam’s Club in 2009 from Linens ’n Things, most recently served as vice president for home. He began his career at May Department Stores. Turner-Mitchael retired effective January 31.
February 12, 2018 by Mark Baumgartner and Chain Drug Review
Centers for Medicare & Medicaid Services, Medicaid, Medicaid work requirements, Trump administration
2018, Issue 02-12-2018, Issues, News
WASHINGTON — The Trump administration has issued guidance that opens the door to work requirements for Medicaid recipients, a major change in the 50-year-old program offering a safety net for Americans living in or near poverty. The White House touted the move for Medicaid work requirements as “making a positive and lasting difference” in the
February 12, 2018 by Bill Schiffner
Albertsons Cos., Bob Miller, Susan Morris, Wayne Denningham
2018, Issue 02-12-2018, Issues, News
BOISE, Idaho — Albertsons Cos. president and chief operating officer Wayne Denningham plans to retire near the end of the company’s fiscal year. Denningham was with the company more than 40 years, having started working as a clerk as a teenager. The company has named Susan Morris executive vice president and chief operations officer, overseeing
February 12, 2018 by Mark Baumgartner and Chain Drug Review
AllianceRx Walgreens Prime, Rick Miller, Walgreens, Walgreens Connected Care Oncology
2018, Issue 02-12-2018, Issues, News
DEERFIELD, Ill. — Walgreens has received a U.S. patent for new proprietary technology that its Walgreens community specialty pharmacists and AllianceRx Walgreens Prime’s specialty pharmacists will use to facilitate communication with and counseling of individuals prescribed oral oncology medicines. The technology will be applied through Walgreens Connected Care Oncology, a process that helps pharmacy customers